GlassScriptPhysician profile
Folayan B Fatade
NPI 1427220235
$3,698.62
in general payments reported to CMS, 2019-2025
15 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,467 · 2020: $420 · 2021: $218 · 2022: $276 · 2023: $24.82 · 2024: $77.47 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,447.45 | 2019-2024 | Indigo System |
| Inari Medical, INC. | $159.78 | 2021 | |
| Stryker Corporation | $144.22 | 2022 | |
| Medtronic USA, INC. | $139.11 | 2019 | |
| Ge Healthcare | $131.22 | 2022-2023 | |
| Angiodynamics, INC. | $114.40 | 2025 | Nanoknife |
| Cardiovascular Systems INC. | $109.06 | 2019 | |
| Boston Scientific Corporation | $105.66 | 2020-2025 | Obsidio |
| Medtronic Vascular, INC. | $89.73 | 2019-2020 | |
| Terumo Medical Corporation | $81.99 | 2020 | |
| Medtronic, INC. | $72.91 | 2021-2025 | Kyphon Express II Kyphopak Tray |
| Biocompatibles, INC. | $30.15 | 2019 | |
| Cardinal Health 200 LLC | $28.05 | 2019 | |
| W. L. Gore & Associates, INC. | $24.88 | 2019 | |
| Abiomed | $20.01 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Folayan Fatade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.